Literature DB >> 16551631

Parathyroid hormone-related protein regulates tumor-relevant genes in breast cancer cells.

Angela Dittmer1, Martina Vetter, Dario Schunke, Paul N Span, Fred Sweep, Christoph Thomssen, Jürgen Dittmer.   

Abstract

The effect of endogenous parathyroid hormone-related protein (PTHrP) on gene expression in breast cancer cells was studied. We suppressed PTHrP expression in MDA-MB-231 cells by RNA interference and analyzed changes in gene expression by microarray analysis. More than 200 genes showed altered expression in response to a PTHrP-specific small interfering (si) RNA (siPTHrP). Cell cycle-regulating gene CDC2 and genes (CDC25B and Tome-1) that control CDC2 activity showed increased expression in the presence of siPTHrP. CDC2 activity was also found to be higher in siPTHrP-treated cells. Studies with PTHrP peptides 1-34 and 67-86, forskolin, and a PTH1 receptor (PTH1R)-specific siRNA showed that PTHrP regulates CDC2 and CDC25B, at least in part, via PTH1R in a cAMP-independent manner. Other siPTHrP-responsive genes included integrin alpha6 (ITGA6), KISS-1, and PAI-1. When combined, siRNAs against ITGA6, PAI-1, and KISS-1 could mimic the negative effect of siPTHrP on migration, whereas siKISS-1 and siPTHrP similarly reduced the proliferative activity of the cells. Comparative expression analyses with 50 primary breast carcinomas revealed that the RNA level of ITGA6 correlates with that of PTHrP, and higher CDC2 and CDC25B values are found at low PTHrP expression. Our data suggest that PTHrP has a profound effect on gene expression in breast cancer cells and, as a consequence, contributes to the regulation of important cellular activities, such as migration and proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551631     DOI: 10.1074/jbc.M510527200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.

Authors:  Jiarong Li; Andrew C Karaplis; Dao C Huang; Peter M Siegel; Anne Camirand; Xian Fang Yang; William J Muller; Richard Kremer
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

2.  Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression.

Authors:  Tingfang Yi; Kunrong Tan; Sung-Gook Cho; Ying Wang; Jian Luo; Wenzheng Zhang; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

3.  Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose.

Authors:  Huasheng Liang; Yuhua Zhong; Yu Huang; Genben Chen
Journal:  Med Oncol       Date:  2011-02-11       Impact factor: 3.064

4.  Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10.

Authors:  Angela Dittmer; Kristina Hohlfeld; Jana Lützkendorf; Lutz P Müller; Jürgen Dittmer
Journal:  Cell Mol Life Sci       Date:  2009-07-15       Impact factor: 9.261

5.  Parathyroid hormone-related protein expression, in combination with nodal status, predicts bone metastasis and prognosis of breast cancer patients.

Authors:  Keiichi Takagaki; Tsutomu Takashima; Naoyoshi Onoda; Kenji Tezuka; Eiji Noda; Hidemi Kawajiri; Tetsuro Ishikawa; Kosei Hirakawa
Journal:  Exp Ther Med       Date:  2012-03-21       Impact factor: 2.447

6.  Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.

Authors:  Sung-Gook Cho; Zhengfang Yi; Xiufeng Pang; Tingfang Yi; Ying Wang; Jian Luo; Zirong Wu; Dali Li; Mingyao Liu
Journal:  Cancer Res       Date:  2009-08-11       Impact factor: 12.701

7.  Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibody.

Authors:  Anne Camirand; Ibtihal Fadhil; Aimée-Lee Luco; Benoît Ochietti; Richard B Kremer
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

8.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

9.  cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells.

Authors:  Annamaria Spina; Francesca Di Maiolo; Antonietta Esposito; Luigi Sapio; Emilio Chiosi; Luca Sorvillo; Silvio Naviglio
Journal:  Biores Open Access       Date:  2012-12

10.  Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.

Authors:  Ilka Oerlecke; Elke Bauer; Angela Dittmer; Benjamin Leyh; Jürgen Dittmer
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.